Brandinium

Trademark search for:

NUCRYST PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2001-11-08 — Application filed
  • 2002-01-14 — Final disposition recorded
  • 2002-07-08 — Paper received
  • 2002-07-08 — Correspondence received in law office
  • 2002-08-12 — Letter of suspension mailed
  • 2003-03-24 — Inquiry as to suspension mailed
  • 2003-08-12 — Paper received
  • 2003-08-12 — Correspondence received in law office
  • 2003-09-06 — Case file in ticrs
  • 2003-09-16 — Letter of suspension mailed
  • 2004-04-20 — Inquiry as to suspension mailed
  • 2004-10-12 — Paper received
  • 2004-10-12 — Correspondence received in law office
  • 2004-10-22 — Amendment from applicant entered
  • 2004-10-25 — Suspension letter written
  • 2004-10-26 — Letter of suspension mailed
  • 2005-01-03 — Use amendment filed
  • 2005-01-03 — Fax received
  • 2005-01-05 — Divisional request received
  • 2005-01-10 — Divisional processing complete
  • 2005-05-12 — Assigned to examiner
  • 2005-05-18 — Suspension checked - to attorney for action
  • 2005-06-10 — Amendment to use processing complete
  • 2005-06-13 — Approved for pub - principal register
  • 2005-06-13 — Use amendment accepted
  • 2005-06-17 — Assigned to lie
  • 2005-06-20 — Law office publication review completed
  • 2005-09-12 — Withdrawn from pub - og review query
  • 2005-09-14 — Previous allowance count withdrawn
  • 2005-11-08 — Examiners amendment mailed
  • 2005-11-08 — Examiners amendment -written
  • 2005-11-08 — Examiner's amendment entered
  • 2005-11-09 — Approved for pub - principal register
  • 2005-11-09 — Examiner's amendment entered
  • 2005-11-10 — Assigned to lie
  • 2005-11-14 — Law office publication review completed
  • 2005-12-14 — Notice of publication
  • 2006-01-03 — Published for opposition
  • 2006-03-28 — Registered-principal register
  • 2012-11-02 — Cancelled sec. 8 (6-yr)
  • 2012-11-02 — Final status recorded

Owner Information

Nucryst Pharmaceuticals Corp.
Alberta T8L 3W4 CA
Nucryst Pharmaceuticals Corp.
Alberta T8L 3W4 CA
Nucryst Pharmaceuticals Corp.
Alberta T8L 3W4 CA

Correspondent

B BRETT HEAVNER FINNEGAN, HENDERSON, FARABOW & ET AL
1300 I ST NW
WASHINGTON, DC 20005-3315
UNITED STATES

Filing Details

Filing Date:
2001-11-08
Status Date:
2012-11-02
Category:
Pharmaceuticals
Filing Year:
2001

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.